Active Ingredient History

  • Now
Birabresib is an experimental small molecule inhibitor of BRD2, BRD3, and BRD4 under investigation for the treatment of cancer. It is in development by Merck & Co. It is currently in clinical trials for leukemia and glioblastoma.   Wikipedia

  • SMILES: Cc1sc2c(C(=N[C@@H](CC(=O)Nc3ccc(O)cc3)c4nnc(C)n24)c5ccc(Cl)cc5)c1C
  • Mol. Mass: 492.0
  • ALogP: 5.53
  • ChEMBL Molecule:
More Chemistry
birabresib | mk-8628 | otx015 | otx-015


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue